All Patients (N=34) |
Patients Failing Conventional Therapy (n=27) | |
ORR, n/N (%) | 22/34 (65)* | 17/27 (63)** |
Time to response, days (median [95% CI]) | 8.0 [5.0-10.0] | 8.0 [7.0-14.0] |
Cumulative duration of response, % days of treatment (median [Q1, Q3]) | 75.7 [33.3-91.2] | 75.4 [30.8-91.2] |
Proceeded to HSCT, n/N (%) | 22/34 (65) | 19/27 (70) |
Overall Survival | ||
Alive at last observations, n/N (%) | 24/34 (70.6) | 20/27 (74.1) |
12-month pOS estimate (% [95% CI]) | 69 [50-82] | 73 [52-86] |
Survival to HSCT, n/N (%)*** | 27/34 (79.4) | 22/27 (81.5) |
Survival post HSCT, n/N (%) | 20/22 (90.9) | 17/19 (89.5) |